Nov. 30, 2009 -
Chart Industries, Inc. (Nasdaq:GTLS) announced that
CAIRE, which operates under Chart's BioMedical segment, has completed the previously announced acquisition of
Covidien's (NYSE:COV) oxygen therapy business, including the design, manufacturing, and sales and service functions worldwide.
The acquisition includes products sold under the leading Companion(TM) and HELiOS(TM) brands. Financial terms of the transaction were not disclosed...
Chart Industries' Press Release -
Covidien's Press Release -
